Application of precision medicine to cervical cancer prevention

• SS 06-02 • Urine based HPV screening in low resource settings > J. Jennifer Smith • SS 06-04 • Risk-based screening and triage: The example of p16/Ki-67 dual stain See abstract > N. Nicolas Wentzensen • SS 06-06 • Optimal methods for cervical cancer screening among HIV positive women See abstract > T. Timothy Wilkin • SS 06-07 • Conclusion: Applying Precision Medicine Initiative to screen and treat HPV associated cancers > A. Anna Giuliano • SS 06-01 • HPV testing as a primary screen in the era of HPV vaccination. A numbers game See abstract > E. Eduardo Franco • SS 06-03 • Host and HPV methylation – adjunctive biomarkers that improve CIN3 diagnosis specificity See abstract > A. Attila Lorincz • SS 06-05 • Application of precision medicine to cervical cancer prevention: Will menopausal women become the highest risk population? See abstract > P. Peter Sasieni